Monitor – New TRPV1-targeting agents for pain management
- 1 December 2005
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 10 (23-24) , 1704-1705
- https://doi.org/10.1016/s1359-6446(05)03677-9
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a Novel Vanilloid Receptor 1 (TRPV1) Antagonist with Antihyperalgesic PropertiesThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Discovery of Potent, Orally Available Vanilloid Receptor-1 Antagonists. Structure−Activity Relationship of N-Aryl CinnamidesJournal of Medicinal Chemistry, 2004
- Vanilloid Receptor TRPV1 Antagonists as the Next Generation of Painkillers. Are We Putting the Cart before the Horse?Journal of Medicinal Chemistry, 2004
- VR1 Receptor Modulators as Potential Drugs for Neuropathic PainMini-Reviews in Medicinal Chemistry, 2003
- Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonistNeuropharmacology, 2003